NCT06844539View on ClinicalTrials.gov

taRgeting bEtA-Cell Function To achIeVe Remission of Type 2 diAbeTEs

NARecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

April 30, 2029

Conditions
Type 2 Diabetes
Interventions
DEVICE

Fully automated insulin delivery with CamAPS HX

Fully automated insulin delivery with CamAPS HX app, Libre 3 glucose sensor and Ypsopump insulin pump.

DEVICE

Standard diabetes therapy with a glucose sensor

Standard diabetes therapy with a Freestyle Libre 3 glucose sensor

Trial Locations (1)

CB2 0QQ

RECRUITING

Addenbrooke's Hospital NHS Foundation Trust, Cambridge

All Listed Sponsors
collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

lead

University of Cambridge

OTHER